Competitive Clinical Research Grant
Lilly’s Competitive Clinical Research Grant funds independent, investigator-initiated clinical studies aligned with its scientific interests, with grantees responsible for study design and conduct.
Funder: Eli Lilly and Company
Due Dates (Anticipated): June 2027 (Full application deadline, projected)
Funding Amounts: Funding levels vary; support typically includes direct research costs and/or study drug; duration based on project scope.
Summary: Supports externally initiated clinical research aligned with Lilly’s scientific interests, with grantees responsible for study design and conduct.
Description
Eli Lilly and Company's Competitive Clinical Research Grant program invites external investigators and institutions to submit proposals for independently initiated clinical research projects that address areas of interest specified in publicly posted Requests for Proposals (RFPs). Research must be independently designed, initiated, and sponsored by the applicant, with Lilly providing funding and/or study drug support for selected projects. Proposals are reviewed by Lilly’s global medical and scientific staff, and may also be evaluated by external experts. Approved grantees retain full responsibility for the design, conduct, and regulatory sponsorship of their research.
